MedTrace Logo

VITdAL@ICU - Correction of Vitamin D Deficiency in Critically Ill Patients

NCT01130181 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 480

Last updated 2014-05-28

No results posted yet for this study

Summary

Study hypothesis:

High-dose vitamin D leads to a shorter hospital stay in critically ill patients

Vitamin D deficient patients will be randomized to receive either 540,000 IU cholecalciferol or placebo.

Conditions

  • Critical Illness
  • Vitamin D Deficiency

Interventions

DRUG

Cholecalciferol

loading dose of 540,000 IU of cholecalciferol via feeding tube or orally, then 5 monthly doses of 90,000 IU

DRUG

Placebo

Matching placebo

Sponsors & Collaborators

  • Harald Dobnig, MD

    lead OTHER

Principal Investigators

  • Harald Dobnig, MD · Medical University of Graz, Austria

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2012-09-30
Completion
2012-09-30

Countries

  • Austria

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01130181 on ClinicalTrials.gov